There are no Transcripts on HRT.
Tue, Mar. 11, 12:47 PM
Thu, Jan. 2, 12:45 PM
Dec. 10, 2013, 12:45 PM
Oct. 8, 2013, 12:45 PM
Aug. 20, 2013, 1:51 PM
- Arrhythmia Research Technology (HRT) says it didn't file its quarterly earnings report by the August 19 due date because of an ongoing review into the valuation of deferred tax assets.
- On a preliminary basis, the company said it expects to report Q2 revenue rose 1.9% to $4.88M from a revised $4.79M a year ago.
- It also sees its net loss for the three months ended in June narrowing to $328,022 from a $1.04M loss in the year-ago period.
- The stock was halted earlier, but has since resumed trading.
Dec. 17, 2012, 12:45 PM
Nov. 23, 2012, 12:45 PM
Oct. 22, 2012, 12:45 PM
HRT vs. ETF Alternatives
Other News & PR